PAUL FELDMAN
Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology NEWBURGH, NY NPI 1497844757
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology NY Amgen Inc. All categories
General Payments — all program years on this page
$8,052.99
- Category: General Payments
- Program years: PY2018–2024
- Record count: 393
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,098.43 across 48 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,033.41 | 46 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $45.00 | 1 |
| Education | $20.02 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $183.09 | 11 |
| Acerta Pharma LLC | $166.58 | 3 |
| Fresenius USA Marketing, Inc. | $144.39 | 6 |
| Takeda Pharmaceuticals U.S.A., Inc. | $95.25 | 4 |
| Novo Nordisk AS | $82.28 | 4 |
| Otsuka America Pharmaceutical, Inc. | $56.34 | 3 |
| Relypsa, Inc. | $55.09 | 3 |
| GlaxoSmithKline, LLC. | $48.39 | 2 |
| BECTON, DICKINSON AND COMPANY | $45.00 | 1 |
| Lilly USA, LLC | $39.37 | 2 |
| ANI Pharmaceuticals, Inc. | $37.14 | 2 |
| Kyowa Kirin, Inc. | $28.43 | 1 |
| AKEBIA THERAPEUTICS INC | $22.13 | 1 |
| Ardelyx, Inc. | $21.85 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.33 | 1 |
| OPKO Pharmaceuticals, LLC | $20.02 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.25 | 1 |
| Aurinia Pharma U.S., Inc. | $13.50 | 1 |
By program year
Records — PY2024 (48)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.